1984
DOI: 10.1016/0091-6749(84)90262-8
|View full text |Cite
|
Sign up to set email alerts
|

Adenosine as a bronchoconstrictor mediator in asthma and its antagonism by methylxanthines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
22
0

Year Published

1986
1986
2010
2010

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(23 citation statements)
references
References 23 publications
1
22
0
Order By: Relevance
“…Therefore, if stimulation of the A 2 receptor results in inhibition of PMN function, then competitive antagonism of the receptor would, potentially, have the opposite (stimulatory) effect. The accepted therapeutic levels of aminophylline and theophylline are comparable to the concentrations associated with adenosine receptor antagonism [21]. Thus, the results with therapeutic levels of aminophylline presented here may be due to A 2 receptor antagonism, whilst at higher concentrations the mechanism of inhibition of cell function is probably due to phosphodiesterase inhibition and elevation of cAMP.…”
Section: Discussionsupporting
confidence: 64%
“…Therefore, if stimulation of the A 2 receptor results in inhibition of PMN function, then competitive antagonism of the receptor would, potentially, have the opposite (stimulatory) effect. The accepted therapeutic levels of aminophylline and theophylline are comparable to the concentrations associated with adenosine receptor antagonism [21]. Thus, the results with therapeutic levels of aminophylline presented here may be due to A 2 receptor antagonism, whilst at higher concentrations the mechanism of inhibition of cell function is probably due to phosphodiesterase inhibition and elevation of cAMP.…”
Section: Discussionsupporting
confidence: 64%
“…The effect may be dependent upon not only a decrease in bronchoconstriction and/or mucosal edema but also antiinflammatory actions, such as the non-selective inhibition of phosphodiesterase, 20) antagonism of adenosine receptor 22,23) and/or activation of histone deacetylate, 24,25) which can lead to reduced levels of cytokines that contribute to the development of LAR and AHR. Furthermore, pranlukast inhibited the LAR and AHR, suggesting that CysLTs are important mediators in the development of these responses.…”
Section: Discussionmentioning
confidence: 99%
“…This nucleoside inhibits respiratory burst activation in human PMNs, an effect which is mediated via binding to external cell membrane regulatory nucleoside receptors (7,8,42). Pentoxifylline is a methylxanthine derivative, and methylxanthines are known inhibitors of nucleoside receptor binding (4,10,11,22) and nucleoside transport (14,30,46). Methylxanthines can also block adenosine activity mediated by regulatory receptors.…”
mentioning
confidence: 99%